openPR Logo
Press release

Airway Stent Market Projected to Reach USD 2.5 Billion by 2034

09-04-2025 03:01 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Airway Stent

Airway Stent

Airway stents play a vital role in maintaining airway patency in patients with obstructive pulmonary diseases, lung cancer, tracheobronchial strictures, and other airway complications. These medical devices help alleviate symptoms such as breathlessness and improve overall quality of life. With the rising incidence of chronic respiratory diseases and lung cancer globally, the demand for airway stents has been increasing steadily.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71511

Recent advances in biomaterials, minimally invasive procedures, and customized stent designs have transformed the treatment landscape. Between 2024 and 2034, the airway stent market is expected to witness significant growth, driven by innovation, an aging population, and increasing adoption of minimally invasive airway management solutions.

Market Overview
The global airway stent market size is estimated at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, growing at a CAGR of 7.8% during the forecast period.

Key highlights:
• Growing prevalence of chronic obstructive pulmonary disease (COPD), lung cancer, and asthma-related complications.
• Increased adoption of minimally invasive bronchoscopy-guided stent placements.
• Technological innovations in stent design, including drug-eluting and biodegradable stents.
• Rising demand for patient-specific and 3D-printed stents.
• North America and Europe dominate, while Asia-Pacific is projected to grow at the fastest rate through 2034.

Market Segmentation
By Product
• Tracheal Stents
• Bronchial Stents
• Tracheobronchial Stents

By Material
• Metallic Stents (Self-Expanding Metallic Stents - SEMS)
• Silicone Stents
• Hybrid Stents (Combination of Metal & Silicone)
• Biodegradable Stents

By Technology
• Drug-Eluting Stents
• 3D-Printed & Customized Stents
• Standard Airway Stents

By Platform
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By End Use
• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Research & Academic Institutions
• Homecare Settings

By Application
• Lung Cancer-Associated Airway Obstruction
• Chronic Obstructive Pulmonary Disease (COPD)
• Tracheobronchomalacia
• Post-Tuberculosis Airway Stenosis
• Other Airway Disorders

Summary of Segmentation
Tracheobronchial stents dominate the market due to their widespread use in lung cancer-related airway obstruction. Metallic stents remain the most common, but silicone and biodegradable stents are gaining traction due to improved biocompatibility and reduced complication rates. Hospitals are the primary end users, but ambulatory centers and homecare-based follow-up services are becoming increasingly important.

Explore Full Report here: https://exactitudeconsultancy.com/reports/71511/airway-stent-market

Regional Analysis
North America
• Largest market in 2024, supported by high prevalence of COPD and lung cancer, advanced healthcare infrastructure, and availability of innovative stents.
• Strong regulatory support and reimbursement frameworks for minimally invasive airway procedures.
Europe
• Second-largest market, led by Germany, the UK, France, and Italy.
• Focus on clinical adoption of 3D-printed and biodegradable stents.
Asia-Pacific
• Fastest-growing market through 2034.
• Large patient pool in China and India, rising healthcare investments, and expanding access to interventional pulmonology.
• Local manufacturing initiatives reduce costs and expand adoption.
Middle East & Africa
• Gradual growth due to improving tertiary healthcare facilities.
• Increasing diagnosis and treatment of airway stenosis in urban centers.
Latin America
• Brazil and Mexico drive regional adoption.
• Public health programs expanding access to bronchoscopy-based procedures.
Regional Summary
While North America and Europe dominate today, Asia-Pacific is the most promising growth region, with rising prevalence of respiratory diseases and improving adoption of advanced stent technologies.

Market Dynamics
Growth Drivers
• Rising prevalence of lung cancer and COPD.
• Increasing adoption of minimally invasive stenting procedures.
• Advances in stent materials and drug-eluting technologies.
• Expanding patient access in emerging markets.

Key Challenges
• Risk of complications such as migration, granulation tissue formation, or infection.
• High costs of advanced stents, limiting adoption in cost-sensitive regions.
• Lack of trained pulmonologists and interventional specialists in developing markets.

Latest Trends
• 3D-printed personalized stents tailored to patient anatomy.
• Development of biodegradable airway stents to reduce long-term complications.
• Growing use of drug-eluting technologies to prevent restenosis.
• Integration of digital imaging and AI for precise stent placement planning.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71511

Competitive Landscape
Major Players
• Boston Scientific Corporation
• Cook Medical
• Teleflex Incorporated
• Merit Medical Systems, Inc.
• Novatech SA
• Bess Medizintechnik GmbH
• Micro-Tech (Nanjing) Co., Ltd.
• Efer Endoscopy
• Endo-Flex GmbH
• Olympus Corporation
• Medi-Tek Instruments
• Taewoong Medical Co., Ltd.

Competition Summary
The airway stent market is moderately consolidated, with Boston Scientific, Cook Medical, and Teleflex leading due to their broad product portfolios. Regional manufacturers, particularly in Asia, are entering the market with cost-effective solutions. Competitive strategies include new product launches, collaborations with hospitals, and adoption of 3D-printing technologies for customized stents.

Conclusion
The airway stent market is set for strong growth through 2034, supported by rising respiratory disease prevalence, growing cancer burden, and advances in stent design. From metallic to biodegradable and 3D-printed stents, innovation is reshaping treatment approaches and improving patient outcomes.

While challenges such as high costs and complication risks persist, opportunities are significant in emerging economies where access to interventional pulmonology is expanding. For global medical device firms, the airway stent market represents both a humanitarian opportunity and a profitable growth segment.

Key Takeaways:
• Market growth will be driven by rising COPD and lung cancer cases worldwide.
• Metallic stents dominate, but silicone, hybrid, and biodegradable stents are the future.
• North America and Europe lead adoption, while Asia-Pacific is the fastest-growing region.
• Competitive edge will be defined by innovation, cost-effectiveness, and partnerships with healthcare providers.

This report is also available in the following languages : Japanese (気道ステント市場), Korean (기도 스텐트 시장), Chinese (气道支架市场), French (Marché des stents pour voies respiratoires), German (Markt für Atemwegsstents), and Italian (Mercato degli stent delle vie aeree), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71511/airway-stent-market#request-a-sample

Our More Reports:

Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease Market
https://exactitudeconsultancy.com/reports/71962/epstein-barr-virus-associated-post-transplant-lymphoproliferative-disease-market

Eye Infections Market
https://exactitudeconsultancy.com/reports/71963/eye-infections-market

Filariasis Market
https://exactitudeconsultancy.com/reports/71964/filariasis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Airway Stent Market Projected to Reach USD 2.5 Billion by 2034 here

News-ID: 4170379 • Views:

More Releases from Exactitude Consultancy

Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patient Pool Analysis Market Projected to Reach USD 5.4 Billion by 2034
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patient Pool Analysis M …
Progressive fibrosing interstitial lung disease (PF-ILD) is an umbrella term describing a group of interstitial lung diseases that share common features such as lung scarring, decline in lung function, and poor prognosis. PF-ILD includes conditions such as idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD, chronic hypersensitivity pneumonitis, and unclassifiable ILD. Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/71509 Over the past decade, PF-ILD has received increased attention due to its
Malignant Pleural Effusion Market Projected to Reach USD 2.8 Billion by 2034
Malignant Pleural Effusion Market Projected to Reach USD 2.8 Billion by 2034
Malignant pleural effusion (MPE) is a severe complication of advanced cancers such as lung, breast, and ovarian cancers. Characterized by the accumulation of fluid in the pleural space due to malignancy, MPE causes significant morbidity, including breathlessness, chest pain, and reduced quality of life. Globally, MPE represents a growing healthcare challenge as cancer incidence rises and survival rates improve, leading to more patients experiencing secondary complications. Download Full PDF Sample Copy
Chronic Refractory Cough Market Projected to Reach USD 4.5 Billion by 2034
Chronic Refractory Cough Market Projected to Reach USD 4.5 Billion by 2034
Chronic refractory cough (CRC) is a persistent cough lasting more than eight weeks that fails to respond to conventional treatment. It is a debilitating condition that significantly impacts quality of life, disrupting sleep, work productivity, and social interaction. Historically overlooked, CRC has recently become a central focus of pharmaceutical research, with new therapies emerging to address the unmet clinical need. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71505 Over the next
Pancreatic Endocrine Tumor (PET) Market Emerging Trends and Growth Prospects 2034
Pancreatic Endocrine Tumor (PET) Market Emerging Trends and Growth Prospects 203 …
Introduction Pancreatic endocrine tumors (PETs), also known as pancreatic neuroendocrine tumors (PNETs), are rare neoplasms originating from the endocrine cells of the pancreas. Unlike pancreatic ductal adenocarcinoma, PETs generally have a slower progression, but they present unique diagnostic and therapeutic challenges due to their heterogeneous nature and variable hormone secretion. The PET market is growing as clinicians and pharmaceutical innovators increasingly focus on rare cancers, supported by advances in precision oncology, targeted

All 5 Releases


More Releases for Stents

Airway Stents (Lung Stents) Research:CAGR of 6.0% during the forecast period
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Airway Stent & Lung Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next
Stents Market
Stents Market, Arteriology stents are tubes that are inserted into the coronary artery to open blockages or stenosis. They are used in a process known as coronary angioplasty or percutaneous coronary intervention (PCI). This method is minimally invasive and is used to treat coronary artery stenosis or narrowing. In the market for cardiac stents globally, technology is crucial. Manufacturers invest much in research and development to create new goods that outperform
Ureteral Stents
Increasing prevalence of urinary incontinence with age and rising geriatric population are major factors expected to drive the ureteral stents market growth during the forecast period. According to the Global Forum for Incontinence held in 2014, incontinence is a serious medical condition and set of diseases, which affected 4% to 8% of the population or the lives of around 400 million people worldwide over a period of 2007-2010. Furthermore, lifestyle associated
Stents Market Demands with Major Types: Coronary Stents, Drug-Eluting Stents (DE …
The “Stents Market Report” gives a clear understanding of the present market condition which includes of historic and projected upcoming Stents industry size, growth, value and volume, projecting cost-effective. Stents Market - Competitive Insights: The leading players in the market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Elixir Medical Corporation and others. Many Key players are depending on methods, for example, agreements & joint ventures, collaborations, and advancements to
Intracranial Stents In Global Market: By Application - Self-expandable Stents & …
Researchmoz added Most up-to-date research on "Intracranial Stents In Global Market: By Application - Self-expandable Stents & Balloon-expanded Stents" to its huge collection of research reports. This report studies Intracranial Stents in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Medtronic Stryker MicroVentionTerumo Abbott Balt Boston Scientific Obex Medical DePuy Synthes (Johnson & Johnson) MicroPort Scientific Market Segment
Europe Intracranial Stents Market For 2017: By Application - Self-expandable Ste …
Researchmoz added Most up-to-date research on "Europe Intracranial Stents Market For 2017: By Application - Self-expandable Stents & Balloon-expanded Stents" to its huge collection of research reports. This report studies sales (consumption) of Intracranial Stents in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Medtronic Stryker MicroVentionTerumo Abbott Balt Boston Scientific Obex Medical DePuy